semaglutide news today 2025 The FDA approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 Drug Watch: The oral version

While there is considerable overlap between firms categorized as State/Local Government in the industry classification and those identified as publicly owned, the two categories are not identical

issued a recall of various NuGO nutrition bars because the bars may contain undeclared milk, a potential allergen

Tip: For best results, use the cream as the final step in your skincare routine to lock in moisture

Its natural to gradually lose collagen and elastin with age, though certain lifestyle habits such as smoking and excessive sun exposure can increase the rate of loss

Evaluation of oxidative stress in patients with acute ischemic stroke